TITLE

Money Raised By Biotech In 2013 vs. 2012

PUB. DATE
May 2013
SOURCE
BioWorld Insight;5/13/2013, Vol. 21 Issue 20, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
A chart is presented which shows money raised by biotech firms the world over from public offerings, public, and private biotechs in 2013 in comparison to 2012.
ACCESSION #
87619286

 

Related Articles

  • Money Raised By Biotech In 2012 vs. 2011.  // BioWorld Insight;12/10/2012, Vol. 20 Issue 50, p1 

    A chart is presented depicting the amount of money raised by biotechnology in the U.S. in 2011 and 2012.

  • Money Raised By Biotech: Jan. 1-Dec. 6, 2012.  // BioWorld Insight;12/10/2012, Vol. 20 Issue 50, p4 

    A chart is presented depicting the money raised by biotechnology in the U.S. from January 1-December 6, 2012.

  • 1Q14-Companies flush, investors snatch profits. Yang, Walter // Nature Biotechnology;May2014, Vol. 32 Issue 5, p410 

    Several charts are presented related to the profits of biotechnology companies as of the first quarter of 2014 including the finance, initial public offerings, and venture capital investment in biotech industry.

  • Public Financing Of Biotechnology: August 2009.  // BioWorld Insight;9/7/2009, Vol. 17 Issue 36, p8 

    Several charts depicting the initial public offerings (IPOs) and follow-on offerings of biotechnology companies in the U.S. as of August 2009 including Cumberland Pharmaceuticals Inc., Ariad Pharmaceuticals Inc., and AVI BioPharma Inc. are presented.

  • Public Financing Of Biotechnology: November 2009.  // BioWorld Insight;12/7/2009, Vol. 17 Issue 49, p7 

    Several charts are presented which depicts the public financing of biotechnology as of November 2009 including initial and follow-on offerings in the trading which commenced in November, and initial offerings that were filed but are still pending.

  • Biotech plummets in 3Q11. Yang, Walter // Nature Biotechnology;Nov2011, Vol. 29 Issue 11, p962 

    Several charts and graphs are presented that depict the performance of the biotechnology industry during the third quarter of 2011, including stock market performance, global industry financing and initial public offerings.

  • Public Financing Of Biotechnology: January 2013.  // BioWorld Insight;2/11/2013, Vol. 21 Issue 7, p7 

    Several tables are presented which list data on biotechnology public financing as of January 2013 including the initial offerings, follow-on offerings, and filed and pending offers.

  • Biotech Companies.  // Inside Tucson Business;7/6/2011, Vol. 21 Issue 6, p7 

    A chart is presented which lists biotech companies in Arizona including Ventana Medical Systems Inc., SynCardia Systems Inc., and Thayer Medical Corp.

  • Bookbuilding vs. Fixed Price: An Analysis of Competing Strategies for Marketing IPOs. Benveniste, Lawrence M.; Busaba, Walid Y. // Journal of Financial & Quantitative Analysis;Dec97, Vol. 32 Issue 4, p383 

    We compare two mechanisms for selling IPOs, the fixed price method and American book-building, when investors have correlated information and can observe each other's subscription decisions. In this environment, the fixed price method is a strategy that can create cascading demand....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics